SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 24th, 2022 • NANOMIX Corp • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March [ ], 2022, between NANOMIX CORPORATION, a Delaware corporation (the “Company”), and the purchaser identified on the signature page hereto (including its successors and assigns, the “Purchaser”).
CONSENT, AMENDMENT AND WAIVERConsent, Amendment and Waiver • March 24th, 2022 • NANOMIX Corp • Pharmaceutical preparations
This CONSENT, AMENDMENT AND WAIVER (this “Consent”) is made and entered into as of March 22, 2022 by and among Nanomix Corporation, a Delaware corporation (which was formerly known as Boston Therapeutics, Inc.) (the “Company”) and HT Investments MA LLC (the “Investor”).
